AstraZeneca surpassed profitability expectations as it disclosed its third-quarter earnings, even as it confronts a significant legal challenge alleging that the effectiveness of its vaccines was greatly exaggerated.
AstraZeneca surpassed profitability expectations as it disclosed its third-quarter earnings, even as it confronts a significant legal challenge alleging that the effectiveness of its vaccines was greatly exaggerated.
In the upcoming week, London’s business scene remains abuzz, with major announcements expected from AstraZeneca, ITV, M&S, Primark’s parent company AB Foods, and Wizz Air, among others.
Shares of AstraZeneca PLC (LSE: AZN) have witnessed a 2% increase, surpassing 11,100p for the first time in a month, following the company’s announcement of promising results from an ongoing
AstraZeneca PLC (LON: AZN) announced that the US Food and Drug Administration (FDA) has requested a risk assessment and mitigation strategy in response to a proposal to broaden the application
AstraZeneca has reported a stronger-than-anticipated performance in the second quarter, with robust sales from its leading cancer drugs offsetting the decline in Covid vaccine sales.
The upcoming week promises to be quite eventful, featuring reporting from five of the FTSE 100’s top ten, as well as four of the major US tech conglomerates. In addition,
The FTSE 100 index had a weak start, posting its poorest opening in three weeks, as industrial miners and lenders dragged it down.
This week is filled with busy results announcements for London-listed companies, with big names like Barclays and NatWest, AstraZeneca and GSK, Unilever and Reckitt Benckiser, as well as US tech
The FTSE 100 achieved a new record high with the help of positive corporate earnings from Centrica and Standard Chartered, while higher commodity prices buoyed miners.
The FTSE 100 has ended the trading day on another record high, closing 1.42pc higher at 7,947.60 points.
The FTSE 100 reached an all-time record, buoyed in part by a string of positive earnings and merger talks linked to Standard Chartered.